LOS ANGELES, CA, UNITED STATES, February 10, 2026 /EINPresswire.com/ — Pulmonary embolisms affect 370,000 patients per year and may cause up to 100,000 deaths per ...
Physicians are sticking with what they know when it comes to prescribing treatment for deep vein thrombosis and pulmonary embolism. Researchers found that the most common treatment remains parenteral ...
Dublin, Dec. 19, 2025 (GLOBE NEWSWIRE) -- The "Pulmonary Embolism Market - A Global and Regional Analysis, 2025-2035" has been added to ResearchAndMarkets.com's offering. The global pulmonary embolism ...
Xarelto approved for pulmonary embolism, DVT The FDA has expanded indications for rivarobaxan to include pulmonary embolism and deep vein thrombosis. The FDA has voted in favor of expanding ...
Internal Jugular, Subclavian, and Axillary Deep Venous Thrombosis and the Risk of Pulmonary Embolism
The objective of this study was to investigate the risk of acute internal jugular, subclavian, and axillary deep venous thrombosis (upper torso DVT [UTDVT]) and pulmonary embolism (PE) and the role of ...
This page contains press release content distributed by XPR Media. Members of the editorial and news staff of the USA TODAY Network were not involved in the creation of this content. LOS ANGELES, CA, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results